Role of PML and PML-RARα in Mad-mediated transcriptional repression

被引:122
|
作者
Khan, MM
Nomura, T
Kim, H
Kaul, SC
Wadhwa, R
Shinagawa, T
Ichikawa-Iwata, E
Zhong, S
Pandolfi, PP
Ishii, S [1 ]
机构
[1] Cornell Univ, Grad Sch Med Sci, Dept Human Genet,Sloan Kettering Div, Mol Biol Program,Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] RIKEN, Tsukuba Inst, Genet Mol Lab, Tsukuba, Ibaraki 3050074, Japan
[3] JST, CREST, Res Project, Tsukuba, Ibaraki 3050074, Japan
[4] Natl Inst Biosci & Human Technol, Agcy Ind Sci & Technol, Tsukuba, Ibaraki 3050046, Japan
[5] Chugai Res Inst Mol Med, Ibaraki, Osaka 3004101, Japan
关键词
D O I
10.1016/S1097-2765(01)00257-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fusion of the promyelocytic leukemia (PML) protein to the retinoic acid receptor-alpha (RAR alpha) generates the transforming protein of acute promyelocytic leukemias. PML appears to be involved in multiple functions, including apoptosis and transcriptional activation by RAR, whereas PML-RAR alpha blocks these functions of PML. However, the mechanisms of leukemogenesis by PML-RAR alpha remain elusive. Here we show that PML interacts with multiple corepressors (c-Ski, N-CoR, and mSin3A) and histone deacetylase 1, and that this interaction is required for transcriptional repression mediated by the tumor suppressor Mad. PML-RAR alpha has the two corepressor-interacting sites and inhibits Mad-mediated repression, suggesting that aberrant binding of PML-RAR alpha to the corepressor complexes may lead to abrogation of the corepressor function. These mechanisms may contribute to events leading to leukemogenesis.
引用
收藏
页码:1233 / 1243
页数:11
相关论文
共 50 条
  • [41] Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RAR' protein degradation
    Wang, Qian Qian
    Zhou, Xin Yi
    Zhang, Yan Fang
    Bu, Na
    Zhou, Jin
    Cao, Feng Lin
    Naranmandura, Hua
    ONCOTARGET, 2015, 6 (28) : 25646 - 25659
  • [42] Novel function for PML-RAR: Interaction with the transcription factor NFY.
    Jansen, JH
    van Wageningen, S
    Nikoloski, G
    de Witte, T
    van der Reijden, BA
    BLOOD, 2002, 100 (11) : 535A - 535A
  • [43] Coexistence of PML-RARα and BCR-ABL in acute promyelocytic leukemia
    Pettijohn, Erin M.
    Platanias, Leonidas C.
    Altman, Jessica K.
    LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 238 - 239
  • [44] PML-RARα融合基因检测方法学的建立
    杨岩
    姚程
    李薇
    易永林
    李舜华
    白求恩医科大学学报, 1997, (01) : 49 - 51
  • [45] The short form of PML-RARα fusion transcript is associated with poor survival
    Albitar, M
    Chang, KS
    Pierce, S
    Kantarjian, H
    Estey, E
    LEUKEMIA RESEARCH, 1999, 23 (01) : 89 - 90
  • [46] PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
    Martens, Joost H. A.
    Brinkman, Arie B.
    Simmer, Femke
    Francoijs, Kees-Jan
    Nebbioso, Angela
    Ferrara, Felicetto
    Altucci, Lucia
    Stunnenberg, Hendrik G.
    CANCER CELL, 2010, 17 (02) : 173 - 185
  • [47] PML-RARα cooperates with activated cytokine receptors to cause acute leukemia
    Phan, VT
    Gonda, TJ
    Hogan, SC
    BLOOD, 2001, 98 (11) : 456A - 456A
  • [48] TRIB3 Promotes APL Development by Stabilization of PML-RARα
    Wang, F.
    Li, K.
    Hua, F.
    Hu, Z. W.
    ANNALS OF HEMATOLOGY, 2017, 96 : S56 - S56
  • [49] Transcriptional repression by the promyelocytic leukemia protein, PML
    Vallian, S
    Gäken, JA
    Trayner, ID
    Gingold, EB
    Kouzarides, T
    Chang, KS
    Farzaneh, F
    EXPERIMENTAL CELL RESEARCH, 1997, 237 (02) : 371 - 382
  • [50] Targeting TRIB3 and PML-RARα interaction against APL
    Li, Ke
    Wang, Feng
    Hu, Zhuo-Wei
    ONCOTARGET, 2017, 8 (32) : 52012 - 52013